Transcript BIO Overview BIO Fact Sheet • • • • Founded: Tax Status: Pres & CEO: Chairman: Non-profit trade association James C.

BIO Overview
BIO Fact Sheet
•
•
•
•
Founded:
Tax Status:
Pres & CEO:
Chairman:
1993
Non-profit trade association
James C. Greenwood
Steve Sherwin
Chairman & CEO
Cell Genesys
• Headquarters:
• Staff:
• Members:
Washington, DC
160
Approximately 1,200 organizations
2
BIO Mission
• Create a positive environment that promotes continued
biotech innovation
• Policy
• Legislative
• Regulatory
• Legal
• Business
• Access to capital
• Partnering
• Public Opinion
• Communications
• Branding campaign
• BIO represents more than just an Industry
• BIO represents Innovation
3
Membership Breakdown
September 2009
Approximately 1,200 Members
$25M - $1B:
5%
Service
Providers:
11%
State/
International
Affiliates:
6%
Less than
$25M:
90%
$1B and
Greater:
5%
R&D
Organizations:
67%
Academic/
Non-Profit:
16%
Health:
88%
~800 R&D Members
Food & Ag:
4%
Industrial &
Environmental:
8%
4
5
6
Unique Trade Association
• Diverse membership – “Big Tent”
• Health, Food & Agriculture, Industrial & Environmental
• Pre-emerging – Fortune 500
• International membership now greater than 20%
• World-class advocacy team
•
•
•
•
Federal & state government relations
International initiative
Policy
Public relations
• Coordinated lobbying effort
•
•
•
•
BIO
Member companies
State affiliates
Coalitions
7
Unique Trade Association
• State affiliate network
• 45 affiliates in 42 states
• Coordinated state-level advocacy in all 42 states
• Membership in BIO provides a voice in affiliate states
• Coalition building
• Patient groups
• Academia
• Other industry groups
• Beyond traditional services
• Business Solutions program for cost savings
• Investor & Innovator conferences among best in the industry
8
2009 Policy Issues
•
•
•
•
•
•
•
Biosimilars
Comparative Effectiveness
Reimbursement: patient access
Improving the performance of FDA
Intellectual property protection
International advocacy
Vaccine innovation & pandemic and bio-defense
preparedness
• Research tools & molecular diagnostics
9
Innovator & Investor Conferences
Innovator:
Investor:
• BIO-Asia
• BIO CEO & Investor
Conference
• BIO-Europe Spring
• BIO National Venture
• BIO-Windhover &
Conference
Windhover PSO
• BIO Investor Forum
• The Business Forum at the
BIO International Convention
• BIO-India
• BIO-Europe
10
Innovator Conference Elements
•
One-on-one partnering meetings
•
Scheduled via BIO’s proprietary online partnering system
•
Company presentations
•
Therapeutic and business expert panels
•
Networking receptions
•
Invitation-only events
11
Communications
• Campaign Goals
• Advance policy goals
•
Build, organize, and have the potential to mobilize a
network of biotech advocates and brand ambassadors
• Increase awareness & favorable opinion of
biotechnology
•
Generate positive awareness among elites and those
who influence opinion and policy
12
Cooperation with China
• BIO China 2010
– Format
• Two day event bringing together biotechnology and
pharmaceutical companies from the US, Europe and Asia.
• Company presentations, partnering (similar to the Business
Forum at the BIO International Convention), and tracks on
timely business development and policy topics.
13
Cooperation with China
• BIO China 2010
– Attendees
• Chinese biotech firms conducting R&D that seek to meet
potential partners.
• International pharmaceutical and biotech companies that
seek to partner with Chinese based R&D companies or to
out-license their technologies.
• China based service providers.
• Innovative biotech companies that seek partners or service
providers.
14
Cooperation with China
• Scientific American Worldview Scorecard
– Launched at BIO 2009.
– Analysis and ranking of biotech environment in countries across
the globe.
– Special look at regulatory, IP, education, infrastructure.
– Focus on China in 2010.
• Government Dialogues
– U.S.-China Joint Commission on Commerce and Trade
– BIO-SFDA Roundtables
15
16